Prevalence of SCN1A-Related Dravet Syndrome among Children Reported with Seizures following Vaccination: A Population-Based Ten-Year Cohort Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Verbeek, Nienke E ^a   van der Maas, Nicoline A T ^b   Jansen, Floor E ^c   van Kempen, Marjan J A ^a   Lindhout, Dick ^a   Brilstra, Eva H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; SODIUM CHANNEL NAV1.1; SCN1A PROTEIN, HUMAN; VIRUS VACCINE;

ADOLESCENT; ARTICLE; BODY TEMPERATURE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; EPILEPSY; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; SCHOOL CHILD; SCN1A GENE; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TEMPERATURE MEASUREMENT; CHEMICALLY INDUCED; EPILEPSIES, MYOCLONIC; GENETIC PREDISPOSITION; GENETICS; MASS IMMUNIZATION; MUTATION; NETHERLANDS; SEIZURES;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPILEPSIES, MYOCLONIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MASS VACCINATION; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; NETHERLANDS; PREVALENCE; SEIZURES; VIRAL VACCINES;

EID: 84878781095     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065758     Document Type: Article

References (39)

1. Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, et al. (1998) Impact of anti-vaccine movements on pertussis control: The untold story. Lancet 351: 356-361.
2. Burgess DC, Burgess MA, Leask J, (2006) The MMR vaccination and autism controversy in united kingdom 1998-2005: Inevitable community outrage or a failure of risk communication? Vaccine 24: 3921-3928 10.1016/j.vaccine.2006.02.033.
3. Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, et al. (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345: 656-661 10.1056/NEJMoa003077.
4. Farrington P, Pugh S, Colville A, Flower A, Nash J, et al. (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345: 567-569.
5. Sun Y, Christensen J, Hviid A, Li J, Vedsted P, et al. (2012) Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and haemophilus influenzae type B. JAMA 307: 823-831 10.1001/jama.2012.165.
6. Ward KN, Bryant NJ, Andrews NJ, Bowley JS, Ohrling A, et al. (2007) Risk of serious neurologic disease after immunization of young children in britain and ireland. Pediatrics 120: 314-321 10.1542/peds.2006-3743.
7. Berkovic SF, Harkin L, McMahon JM, Pelekanos JT, Zuberi SM, et al. (2006) De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: A retrospective study. Lancet Neurol 5: 488-492 10.1016/S1474-4422(06)70446-X.
8. Yakoub M, Dulac O, Jambaque I, Chiron C, Plouin P, (1992) Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 14: 299-303.
9. Hurst DL, (1990) Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 31: 397-400.
10. Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM, (2012) Prognostic, clinical and demographic features in SCN1A mutation-positive dravet syndrome. Brain 135: 2329-2336 10.1093/brain/aws151; 10.1093/brain/aws151.
11. Dravet C, (2011) The core dravet syndrome phenotype. Epilepsia 52 (Suppl 2) (): 3-9 10.1111/j.1528-1167.2011.02994.x; 10.1111/j.1528-1167.2011.02994.x.
12. Depienne C, Trouillard O, Saint-Martin C, An I, Bouteiller D, et al. (2009) Spectrum of SCN1A gene mutations associated with dravet syndrome: Analysis of 333 patients. J Med Genet 46: 183-191 10.1136/jmg.2008.062323.
13. Mulley JC, Scheffer IE, Petrou S, Dibbens LM, Berkovic SF, et al. (2005) SCN1A mutations and epilepsy. Hum Mutat 25: 535-542 10.1002/humu.20178.
14. Depienne C, Trouillard O, Gourfinkel-An I, Saint-Martin C, Bouteiller D, et al. (2010) Mechanisms for variable expressivity of inherited SCN1A mutations causing dravet syndrome. J Med Genet 47: 404-410 10.1136/jmg.2009.074328.
15. De Jonghe P, (2011) Molecular genetics of dravet syndrome. Dev Med Child Neurol 53 (Suppl 2) (): 7-10 10.1111/j.1469-8749.2011.03965.x; 10.1111/j.1469-8749.2011.03965.x.
16. McIntosh AM, McMahon J, Dibbens LM, Iona X, Mulley JC, et al. (2010) Effects of vaccination on onset and outcome of dravet syndrome: A retrospective study. Lancet Neurol 9: 592-598 10.1016/S1474-4422(10)70107-1.
17. Tro-Baumann B, von Spiczak S, Lotte J, Bast T, Haberlandt E, et al. (2011) A retrospective study of the relation between vaccination and occurrence of seizures in dravet syndrome. Epilepsia 52: 175-178 10.1111/j.1528-1167.2010.02885.x; 10.1111/j.1528-1167.2010.02885.x.
18. Nieto-Barrera M, Lillo MM, Rodriguez-Collado C, Candau R, Correa A, (2000) Severe myoclonic epilepsy in childhood. epidemiologic analytical study. Rev Neurol 30: 620-624.
19. Caraballo RH, Fejerman N, (2006) Dravet syndrome: A study of 53 patients. Epilepsy Res 70 (Suppl 1) (): S231-8 10.1016/j.eplepsyres.2005.11.026.
20. Ceulemans B, Boel M, Claes L, Dom L, Willekens H, et al. (2004) Severe myoclonic epilepsy in infancy: Toward an optimal treatment. J Child Neurol 19: 516-521.
21. van Lier EA, van Oomen PJ, Oostenbrug MWM, Zwakhals SLN, Drijfhout IH, et al. (2008) Vaccinatiegraad rijksvaccinatieprogramma nederland; verslagjaar 2006-2008 (immunization coverage national immunization programme in the netherlands, year of report 2006-2008). RIVM Report 210021007.
22. van der Maas NA, Phaff TAJ, Wesselo C, Vermeer-de Bondt PE. (2007) Adverse events following immunizations under the national vaccination programme of the netherlands. number XIII-reports in 2006. RIVM Report 240071004.
23. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W, (1991) Risk of seizures after measles-mumps-rubella immunization. Pediatrics 88: 881-885.
24. Vermeer-de Bondt PE, Wesselo C, Dzaferagic A, Phaff TAJ. (2002) Adverse events following immunisation under the national vaccination programme of the netherlands. number VII- reports in 2000. RIVM Report 000001006.
25. Abbink F, van der Avoort HGAM, Berbers WAM, van Binnendijk RS, Boot HJ, et al. (2006) Het rijksvaccinatieprogramma nu en in de toekomst: Ontwikkelingen in 2005 (the national immunisation programme now and in the future: Developments in 2005). RIVM Report 210021004.
26. Bonhoeffer J, Menkes J, Gold MS, de Souza-Brito G, Fisher MC, et al. (2004) Generalized convulsive seizure as an adverse event following immunization: Case definition and guidelines for data collection, analysis, and presentation. Vaccine 22: 557-562.
27. Verbeek NE, van Kempen M, Gunning WB, Renier WO, Westland B, et al. (2011) Adults with a history of possible dravet syndrome: An illustration of the importance of analysis of the SCN1A gene. Epilepsia 52: e23-5 10.1111/j.1528-1167.2011.02982.x; 10.1111/j.1528-1167.2011.02982.x.
28. Fountain-Capal JK, Holland KD, Gilbert DL, Hallinan BE, (2011) When should clinicians order genetic testing for dravet syndrome? Pediatr Neurol 45: 319-323 10.1016/j.pediatrneurol.2011.08.001.
29. Scheffer IE, Berkovic SF, (1997) Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120 (Pt 3) (): 479-490.
30. Marini C, Mei D, Temudo T, Ferrari AR, Buti D, et al. (2007) Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia 48: 1678-1685 10.1111/j.1528-1167.2007.01122.x.
31. Ottman R, Hirose S, Jain S, Lerche H, Lopes-Cendes I, et al. (2010) Genetic testing in the epilepsies-report of the ILAE genetics commission. Epilepsia 51: 655-670 10.1111/j.1528-1167.2009.02429.x.
32. David S, Vermeer-de Bondt PE, van der Maas NA, (2008) Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the netherlands. Vaccine 26: 5883-5887 10.1016/j.vaccine.2008.07.105.
33. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, et al. (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. progetto pertosse working group. N Engl J Med 334: 341-348 10.1056/NEJM199602083340601.
34. Hattori J, Ouchida M, Ono J, Miyake S, Maniwa S, et al. (2008) A screening test for the prediction of dravet syndrome before one year of age. Epilepsia 49: 626-633 10.1111/j.1528-1167.2007.01475.x.
35. Centraal Bureau voor de Statistiek (Statistics Netherlands), statline website. Available: http://statline.cbs.nl/StatWeb/publication/?DM=SLEN&PA=37422ENG&D1=0,4-5&D2=47-56&LA=EN&HDR=G1,T&VW=T. Accessed 2013 Jan 17.
36. von Spiczak S, Helbig I, Drechsel-Baeuerle U, Muhle H, van Baalen A, et al. (2011) A retrospective population-based study on seizures related to childhood vaccination. Epilepsia 52: 1506-1512 10.1111/j.1528-1167.2011.03134.x; 10.1111/j.1528-1167.2011.03134.x.
37. Reyes IS, Hsieh DT, Laux LC, Wilfong AA, (2011) Alleged cases of vaccine encephalopathy rediagnosed years later as dravet syndrome. Pediatrics 10.1542/peds.2010-0887.
38. van der Maas NA, David S, Kemmeren JM, Vermeer-de Bondt PE, (2007) Safety surveillance in the national vaccination programme; fewer adverse events with the DTP-IPV-hib vaccine after the transition to an acellular pertussis component in 2005. Ned Tijdschr Geneeskd 151: 2732-2737.
39. World health organization website. Available:http://apps.who.int/vaccines/globalsummary/immunization/ScheduleSelect.cfm. Accessed 2013 Jan 17.